CHADDS FORD, Pa., April 13 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals and Penwest Pharmaceuticals announced today that the companies have settled litigation with Barr Laboratories, Inc. regarding the production and sale of generic formulations of Opana(R) ER (oxymorphone hydrochloride) Extended Release Tablets CII.
About Endo
Forward Looking Statement
Endo Pharmaceuticals
